Compare · BBLN vs OPCH
BBLN vs OPCH
Side-by-side comparison of Babylon Holdings Limited (BBLN) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBLN and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.22B, about 1.4x BBLN ($2.27B).
- OPCH has hit the wire 12 times in the past 4 weeks while BBLN has been quiet.
- OPCH has more recent analyst coverage (14 ratings vs 9 for BBLN).
- Company
- Babylon Holdings Limited
- Option Care Health Inc.
- Price
- $0.55-13.27%
- $20.48+2.02%
- Market cap
- $2.27B
- $3.22B
- 1M return
- -
- +0.17%
- 1Y return
- -
- -35.33%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 0
- 12
- Recent ratings
- 9
- 14
Babylon Holdings Limited
Babylon Holdings Limited operates as a digital healthcare company in the United Kingdom and internationally. Its digital-first platform provides with assistance to navigate the health system by connecting patients digitally to the clinicians. The company was founded in 2013 and is headquartered in London, the United Kingdom.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest BBLN
- Babylon Holdings Limited filed SEC Form 8-K: Other Events
- Babylon Holdings Limited filed SEC Form 8-K: Other Events
- SEC Form NT 10-Q filed by Babylon Holdings Limited
- Babylon Holdings Limited filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Babylon Holdings Limited filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Babylon Holdings Limited
- SEC Form 4 filed by Vnv Global Ab (Publ)
- SEC Form SC 13D/A filed by Babylon Holdings Limited (Amendment)
- SEC Form 4 filed by Vnv Global Ab (Publ)
- Babylon Holdings Announces Receipt Of Continued Listing Standards Notice From NYSE And Upcoming Delisting
Latest OPCH
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)
- Director Brandt Eric was granted 11,640 shares, increasing direct ownership by 112% to 21,999 units (SEC Form 4)